Celebrities may have glam squads and access to the best doctors and treatments in the world — and yet even they have skin ...

Skinification of hair is about applying the same care, attention and hero ingredients to products that enhance scalp and hair health. It used to be that scalp care was only ever associated with the ...

Arthritis doesn’t always begin with obvious joint pain. In fact, sometimes, its symptoms can be really subtle and unexpected. Over 10 million adults, young people and children in the UK live with ...

Ixekizumab plus tirzepatide (IXE+TZP) shows significant benefits over ixekizumab (IXE) alone in adults with active psoriatic arthritis (PsA) who are overweight or have obesity, according to a study ...

The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has accepted its supplemental biologics license application for the indication of ...

What Is Sotyktu, and Why Does It Matter? Sotyktu (deucravacitinib) is an oral selective tyrosine kinase 2 (TYK2) inhibitor used to treat autoimmune inflammatory diseases such as plaque psoriasis in ...

In a dizzying span of seven months in 2022, Bristol Myers Squibb gained FDA approval for three new products, touting each with the potential to achieve $4 billion in peak sales. While multiple myeloma ...

Please provide your email address to receive an email when new articles are posted on . Dual therapy with GLP-1s and ixekizumab was associated with improvements in both psoriasis and PsA.

(RTTNews) - Bristol Myers Squibb (BMY) announced that the U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis (PsA).

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results ⁠in patients with the skin disease and obesity in a late-stage study, compared to ...

Psoriatic arthritis (PsA) is an autoimmune disease that causes inflammation of the joints, tendons, and nails. It usually occurs in people with psoriasis, an inflammatory condition causing rashes on ...

Researchers have figured out how psoriasis can quietly turn into joint disease for some patients. Immune cells formed in inflamed skin can travel through the blood and reach the joints, where they ...